Icosavax Inc.

NASDAQ: ICVX · Real-Time Price · USD
15.31
-0.14 (-0.91%)
At close: Feb 16, 2024, 10:00 PM

Icosavax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
582K 7.8M
Cost of Revenue
1.84M 82K
Gross Profit
-1.26M 7.72M
Operating Income
-95.06M -65.86M
Interest Income
n/a 151K
Pretax Income
-91.76M -66.97M
Net Income
-88.46M -68M
Selling & General & Admin
30.23M 34.89M
Research & Development
65.41M 38.78M
Other Expenses
-582K -7.8M
Operating Expenses
95.06M 65.86M
Interest Expense
n/a 151K
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
95.06M 65.86M
Income Tax Expense
-3.3M 1.03M
Shares Outstanding (Basic)
39.73M 17.97M
Shares Outstanding (Diluted)
39.73M 17.97M
EPS (Basic)
-2.23 -3.78
EPS (Diluted)
-2.23 -3.78
EBITDA
-95.06M -64.9M
EBIT
-95.06M -66.82M
Depreciation & Amortization
860K 959K